Inactive
Notice ID:JA22-07-1204
THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. The United Stated Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate o...
THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. The United Stated Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW FAR 13.106, with Worcester Polytechnical Institute (WPI) Integrated Circuits and Systems Laboratory 100 Institute Road Worcester, MA 01609, USA, as the only responsible source that can provide 80 fully tested and functioning prototypes of their Transcutaneous Oxygen Monitor (TOM) for deployment in a high altitude research setting. This acquisition is being conducted under FAR Part 12 Acquisition of Commercial Items. Provisions and clauses in effect through Federal Acquisition Circular 2022-08 are incorporated. The US Army Research Institute of Environmental Medicine (USARIEM) intends to procure a firm-fixed-price contract with a base and one option year. WPI will provide 80 fully tested and functioning prototypes of their Transcutaneous Oxygen Monitor (TOM) for deployment in a high altitude research setting. The TOM devices will exhibit the capability to noninvasively record and store parameters relevant to assessing early detection of oxygen deficiency in soldiers at high altitude and be free of motion artifact. The TOM device will weigh less than 20 grams and will have a footprint of no more than 50mm x 70mm. The TOM device should indicate the partial pressure of O2 (cutaneous PO2) to within 5 mmHg over the range from 0-20.9% O2, and to within 10 mmHg over the range from 20.9-100% O2. The TOM device will be packaged in sterile blister packaging with a footprint of no more than 70mm x 90mm. The TOM device should have a shelf life of one year and work under both stationary and moving conditions. Devices should also be cost-effective with a portable form factor compared to established commercial and military solutions. The following deliverables are requested from this effort: Quarterly reports summarizing design, fabrication, technical specifications and manufacturing of prototype transcutaneous oxygen monitor (TOM) devices An interim report summarizing results from testing of 5-10 TOM prototypes 80 working TOM devices in sterile blister packaging TOM operating manual detailing proper use of devices Statistical analysis report of data collected from TOM compared to gold-standard finger pulse oximeter devices Final technical report summarizing findings of the above comparison study As part of an ongoing effort to accelerate data collection for the Defense Health Program (DHP) funded research project entitled “Development of an individualized real-time hypoxic monitoring system to enhance health, performance, and readiness at altitude”, USARIEM seeks to collaborate with Worcester Polytechnic Institute’s Integrated Circuits and Systems Laboratory (WPI ICASLab) to facilitate the continued development, testing, and deployment of the Transcutaneous Oxygen Monitor (TOM) prototype in a high-altitude setting. The USARIEM Principal Investigator has previously worked with WPI to develop an earlier version of the TOM sensor, which WPI plans to expand upon to achieve the updated desired performance objectives. The TOM proposed to be developed and produced by WPI is a prototype and its design is unique to fit a desired list of specifications as stated in the description of services and supplies above. The devices will be tested by USARIEM personnel in a sea level laboratory (<1500m) and high-altitude environment (> 3000 meters above sea level) under an IRB approved protocol. The intended procurement will be classified under North American Industry Classification System (NAICS) 541715 with a Small Business Size Standard of 1000 employees and the PSC is AF12. This notice of intent is not a request for competitive proposals and no solicitation document will be posted for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Submit email capabilities statements (using PDF, MS Word, Excel attachments) to Kasey Carroll at kasey.l.carroll.civ@health.mil. Statements are due no later than 1:00 P.M. EST on 7 September 2022. Late responses will not be reviewed.